ORNL, UT project could save vision of millionsFebruary 18, 2009In the blink of an eye, people at risk of becoming blind can now be screened for eye diseases such as diabetic retinopathy and age-related macular degeneration. Using a technology originally developed at the Department of Energy's Oak Ridge National Laboratory to understand semiconductor defects, three locations in Memphis have been equipped with digital cameras that take pictures of the retina. Those images are relayed to a center where they are analyzed and the patient knows in minutes whether he or she needs additional medical attention. "Once we've taken pictures of the eyes, we transmit that information to our database, where it is compared to thousands of images of known retinal disease states," said Ken Tobin, who led the ORNL team that developed the technology. "From there, the computer system is able to determine whether the patient passes the screening or it provides a follow-up plan that includes seeing an ophthalmologist." Already, this technology is making a difference as two patients at the Church Health Center in Memphis have been identified as needing laser treatment for moderate and severe diabetic retinopathy and macular edema, both conditions that can lead to blindness. While some cameras have been installed, others will be installed at several rural and urban health care centers serving the Mississippi Delta. Another camera is planned for a federally funded health center in Chattanooga. Eventually, the goal is to have hundreds of cameras throughout the United States and beyond. If disease can be detected early, treatments can preserve vision and significantly reduce the occurrence of debilitating blindness. This project takes advantage of ORNL's proprietary content-based image retrieval technology, which quickly sorts through large databases and finds visually similar images. For more than a decade manufacturers of semiconductors have used this technology to rapidly scan hundreds of thousands of tiny semiconductors to learn quickly about problems in the manufacturing process. "Our approach allows us to adapt a proven technology to describe key regions of the retina, and this information can then be used to index images in a content-based image retrieval library," Tobin said. "What separates this from other methods is that we have automated the process of diagnosing retinal disease by capturing the expert knowledge of an ophthalmologist in a patient archive." Leading the medical portion of the project is Edward Chaum, an ophthalmologist and Plough Foundation professor of retinal diseases at the University of Tennessee Health Science Center (http://www.eye.utmem.edu) Hamilton Eye Institute in Memphis. Chaum, the lead researcher on the National Eye Institute grant that has funded much of this research, is especially excited about the number of people, particularly the indigent and medically underserved communities, that this technology will help. "Right now, with 21 million diabetics in the United States, we need to be screening 400,000 patients for diabetic eye disease every week," Chaum said. "Less than half of these diabetics receive the recommended annual eye exam, which is absolutely essential to minimize serious eye complications and potential blindness." By 2050 the number of diabetics in the United States is expected to double, so the task of screening patients becomes even more daunting. Looking beyond the United States and more near term, the World Health Organization estimates that by 2025 more than 1 million patients will need to be screened worldwide for diabetes every day. "To reach this goal, we are going to have to change the health care delivery paradigm," Chaum said, "and that will mean distributing these cameras to clinics and offices of primary care physicians." Over the next few months, a more fully automated image analysis network managing images nationwide -- and eventually worldwide -- will be rolled out, according to Chaum, who envisions this being a global effort using automated technology and the connectivity of the World Wide Web. Other researchers involved in this project are Tom Karnowski and Luca Giancardo of ORNL's Measurement Science and Systems Engineering Division, Stacy Li of the University of Tennessee Health Science Center in Memphis and Karen Fox of the Delta Health Alliance. DOE/Oak Ridge National Laboratory |
|||||||||||||||||||||
| Related Diabetic Retinopathy Current Events and Diabetic Retinopathy News Articles Cataract surgery helps AMD patients; steroid improves DME; online eye health forum This month's Ophthalmology, the journal of the American Academy of Ophthalmology (Academy) reports on a national study that finds cataract surgery is likely to benefit patients with age-related macular degeneration (AMD) at all stages of the disease, on a clinical trial showing that the steroid triamcinolone may be effective in advanced diabetic macular edema (DME) patients when standard treatment fails, and on the public's use of two Academy-sponsored online eye health forums. Clues to visual variant Alzheimer's; myopia and diabetic retinopathy risk Two studies are of particular note in today's Scientific Program of the 2009 Joint Meeting of the American Academy of Ophthalmology (AAO) and the Pan-American Association of Ophthalmology (PAAO): a report by Swiss neuro-ophthalmic researchers about vision exam clues that should make ophthalmologists suspect an atypical variant of Alzheimer's disease; and new evidence from a Singapore National Eye Center study that diabetics who are nearsighted may be less susceptible to diabetic retinopathy. Treating ROP in tiny preemies; better glaucoma follow-up in urban clinic Highlights of today's Scientific Program of the 2009 American Academy of Ophthalmology (AAO) - Pan-American Association of Ophthalmology (PAAO) Joint Meeting include: John T. Flynn, MD, Columbia University School of Medicine, discussing the ever-tougher challenges Eye M.D.s face in caring for the vision of the tiniest premature babies; and a report by Bradford W. Lee, MD, Stanford University School of Medicine, on barriers to glaucoma follow-up as perceived by patients in an urban, culturally diverse clinic. First in New York: Bionic technology aims to give sight to woman blinded beginning at age 13 A 50-year-old New York woman who was diagnosed with a progressive blinding disease at age 13 was implanted with an experimental electronic eye implant that has partially restored her vision. Elevated arginase levels contribute to vascular eye disease such as diabetic retinopathy Elevated levels of the enzyme arginase contribute to vascular eye damage and Medical College of Georgia researchers say therapies to normalize its levels could halt progression of potentially blinding diseases such as diabetic retinopathy. Natural Compound Stops Diabetic Retinopathy Researchers at the University of Oklahoma Health Sciences Center have found a way to use a natural compound to stop one of the leading causes of blindness in the United States. Erectile dysfunction treatments do not appear to damage vision over 6 months Two medications used to treat erectile dysfunction in men (tadalafil and sildenafil) do not appear to have visual side effects when taken daily for six months, despite concerns about eye-related complications. Growth factor TGF-B helps maintain health of retinal blood vessels Scientists at Schepens Eye Research Institute have found that the growth factor known as TGF-β is essential to the health of blood vessels in the retina and that blocking it can cause retinal dysfunction. South Asians with diabetes more likely to lose their eyesight earlier than White Europeans South Asians with type 2 diabetes are significantly more at risk of losing their eyesight and losing it at an earlier age, compared to White Europeans with the same condition. Shining light on diabetes-related blindness A group of scientists in California is trying to develop a cheaper, less invasive way to spot the early stages of retinal damage from diabetic retinopathy, the leading cause of blindness in American adults, before it leads to blindness. More Diabetic Retinopathy Current Events and Diabetic Retinopathy News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||